The novel cystatin C, lactate, interleukin-6, and N-terminal pro-B-type natriuretic peptide (CLIP)-based mortality risk score in cardiogenic shock after acute myocardial infarction

Application of the SCAI classification in a cohort of patients with cardiogenic shock

(2020) Benedikt Schrage et al.   CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS

Standardized Team-Based Care for Cardiogenic Shock

(2019) Behnam N. Tehrani et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Management of cardiogenic shock complicating myocardial infarction: an update 2019

(2019) Holger Thiele et al.   EUROPEAN HEART JOURNAL

Protein-based cardiogenic shock patient classifier

(2019) Ferran Rueda et al.   EUROPEAN HEART JOURNAL

Cardiogenic Shock Classification to Predict Mortality in the Cardiac Intensive Care Unit

(2019) Jacob C. Jentzer et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Cystatin C for Risk Stratification in Patients After an Acute Coronary Syndrome

(2018) Simon Correa et al.   Journal of the American Heart Association

Risk Stratification for Patients in Cardiogenic Shock After Acute Myocardial Infarction

(2017) Janine Pöss et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock

(2017) Holger Thiele et al.   NEW ENGLAND JOURNAL OF MEDICINE

Prediction models need appropriate internal, internal–external, and external validation

(2016) Ewout W. Steyerberg et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): The TRIPOD Statement

(2015) Gary S. Collins et al.   ANNALS OF INTERNAL MEDICINE

Angiopoietin-2 in acute myocardial infarction complicated by cardiogenic shock-a biomarker substudy of the IABP-SHOCK II-Trial

(2015) Janine Pöss et al.   EUROPEAN JOURNAL OF HEART FAILURE

Clinical picture and risk prediction of short-term mortality in cardiogenic shock

(2015) Veli-Pekka Harjola et al.   EUROPEAN JOURNAL OF HEART FAILURE

Prognostic impact of established and novel renal function biomarkers in myocardial infarction with cardiogenic shock: A biomarker substudy of the IABP-SHOCK II-trial

(2015) Georg Fuernau et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Towards better clinical prediction models: seven steps for development and an ABCD for validation

(2014) E. W. Steyerberg et al.   EUROPEAN HEART JOURNAL

Growth-differentiation factor 15 and osteoprotegerin in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the IABP-SHOCK II-trial

(2014) Georg Fuernau et al.   EUROPEAN JOURNAL OF HEART FAILURE

Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial

(2013) Holger Thiele et al.   LANCET

Cystatin C versus Creatinine in Determining Risk Based on Kidney Function

(2013) Michael G. Shlipak et al.   NEW ENGLAND JOURNAL OF MEDICINE

Intraaortic Balloon Support for Myocardial Infarction with Cardiogenic Shock

(2012) Holger Thiele et al.   NEW ENGLAND JOURNAL OF MEDICINE

A severity scoring system for risk assessment of patients with cardiogenic shock: A report from the SHOCK Trial and Registry

(2010) Lynn A. Sleeper et al.   AMERICAN HEART JOURNAL

Early Risk Stratification of Patients With Cardiogenic Shock Complicating Acute Myocardial Infarction Who Undergo Percutaneous Coronary Intervention

(2009) Ana Garcia-Alvarez et al.   AMERICAN JOURNAL OF CARDIOLOGY

Macrophage responses to interferon-γ are dependent on cystatin C levels

(2009) Katarina H. Frendéus et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Updating methods improved the performance of a clinical prediction model in new patients

(2007) K.J.M. Janssen et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY